Liver miR-21 is overexpressed in patients with NASH, and miR-21 inhibition or suppression decreases hepatic injury, inflammation, and fibrosis, by restoring PPARα expression [121]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.